| Heart Of Hospice, Llc 1100 Bertrand Drive, Lafayette, LA, 70506 | |
| (337) 232-8159 |
News Archive
BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.
› Verified 4 days ago
| Name | Heart Of Hospice, Llc |
|---|---|
| Location | 1100 Bertrand Drive, Lafayette, Louisiana |
| Hospice ID | 191638 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Other |
| Profit Type | FOR PROFIT |
| SSA county code | 270 |
News Archive
BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.
› Verified 4 days ago
| NPI Number | 1215084520 |
| Organization Name | Heart Of Hospice, Llc |
| Address | 201 W Vermilion St Lafayette, Louisiana, 70501 |
| Phone Number | (337)232-8159 |
News Archive
BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.
› Verified 4 days ago
| NPI Number | 1467854158 |
| Organization Name | Heart Of Hospice Llc |
| Address | 1100 Bertrand Dr Lafayette, Louisiana, 70506 |
| Phone Number | (337)232-8159 |
News Archive
BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.
› Verified 4 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 99.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 96.1 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.6 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 89.8 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.3 | 97.3 |
| Patients who got timely treatment for shortness of breath | 98.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 96.9 | 93.3 |
News Archive
BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.
› Verified 4 days ago
| Home Health Aides | 11 |
| Counselors | 3 |
| Medical Social Workers | 4 |
| Registered Nurses | 19 |
| Other Personnel | 5 |
| Total Employees | 42 |
|---|
News Archive
BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.
› Verified 4 days ago
| Others | 26 |
| Total Volunteers | 26 |
|---|
News Archive
BioClinica®, Inc.,, a global provider of clinical trial management solutions, today announced a new agreement with Cato Research Ltd., a full-service contract research organization. Cato Research selected BioClinica's clinical trial management system (CTMS) platform in its search for a best-in-class solution to better serve its growing worldwide client base.
Preventable childhood deaths caused by illnesses such as pneumonia and diarrhea can be nearly eliminated in 10 years according to researchers from the Johns Hopkins Bloomberg School of Public Health and the National Institutes of Health. In a new commentary featured in the June issue of the Journal of the American Medical Association, researchers outline a strategy and benchmarks for curbing childhood preventable deaths and recommend a new common vision for a global commitment to end all preventable child deaths.
Esperion Therapeutics, a privately held biotechnology company working to discover, develop and commercialize treatments for cardiovascular and metabolic diseases, today announced that the company has initiated a Phase I clinical study for ETC-1002, the company's novel small molecule compound designed to beneficially regulate the levels of plasma lipids and lipoproteins.
Baylor Health Care System announced today the opening of a new Diabetes Health and Wellness Institute in an underserved community in South Dallas that it believes will ultimately influence the way diabetes is treated and prevented around the country.
The 2009 Cumulative Supplement to Pharmaceutical Patent Law delivers the latest legal developments in pharmaceutical patent law.
› Verified 4 days ago
| Hospice Of Acadiana Inc Location: 2600 Johnston Street, Suite 200, Lafayette, Louisiana, 70503 Phone: (337) 232-8159 |
| Acadian Hospice And Palliative Care Location: 458 Heymann Blvd, Bldg A, Lafayette, Louisiana, 70503 Phone: (337) 232-8159 |
| Angel Care Hospice Location: 1406 Ne Evangeline Thruway, Suite 100, Lafayette, Louisiana, 70501 Phone: (337) 232-8159 |
| Nsi Hospice, Llc Location: 1025 Camellia Blvd Ste 201, Lafayette, Louisiana, 70508 Phone: (337) 232-8159 |